SOL Solana BullRun Confirmed - SOL Price Prediction
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 22 Sept 2026, 11:00 UTC
- Recorded by Tahlil Plus
- 22 Sept 2026, 12:45 UTC
AI-generated source summary
The analysis focuses on Solana (SOL) with a bullish outlook on a weekly timeframe. The current price is approximately $117.22, with a target price projected at $150.00. The fail-bound, indicating invalidation of the bullish scenario, is set at $105.00. The analysis of TOTAL and TOTAL2 charts suggests a potential beginning of a new bull market cycle for the broader cryptocurrency market. The BTC.D chart shows potential for a downtrend, which historically correlates with altcoin season and a subsequent rise in altcoin market caps. The analysis implies that if these broader market trends continue, SOL is poised for further upside. The projected upward movement for SOL is expected to follow a pattern of consolidation and upward acceleration, aiming for new all-time highs. The overall sentiment is bullish for SOL and the broader altcoin market, contingent on maintaining key support levels and favorable macroeconomic conditions indicated by the crypto market cap trends.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.